 | • レポートコード：QYR2104Z0417 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、抗結核治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（イソニアジド、リファンピン、エタンブトール、ピラジナミド、その他）、用途別市場規模（病院・クリニック、政府機関、非営利団体、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・抗結核治療の市場動向 ・企業の競争状況、市場シェア ・抗結核治療の種類別市場規模（イソニアジド、リファンピン、エタンブトール、ピラジナミド、その他） ・抗結核治療の用途別市場規模（病院・クリニック、政府機関、非営利団体、その他） ・抗結核治療の北米市場規模2016-2027（アメリカ、カナダ） ・抗結核治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・抗結核治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・抗結核治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・抗結核治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Lupin、Macleods Pharmaceuticals、Otsuka Pharmaceutical、Johnson & Johnson、Pfizer、Novartis、Abbott、AstraZeneca、Bayer、Eli Lilly、GlaxoSmithKline、Merck、Sanofi） ・結論 |
Tuberculosis (TB) is a disease affecting the population across the world. Although tuberculosis is a curable disease, it still remains one of the most common causes of death among adults, particularly in the emerging economies.
Market Analysis and Insights: Global Anti-tuberculosis Therapeutics Market
The global Anti-tuberculosis Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anti-tuberculosis Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anti-tuberculosis Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anti-tuberculosis Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anti-tuberculosis Therapeutics market.
Global Anti-tuberculosis Therapeutics Scope and Market Size
Anti-tuberculosis Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti-tuberculosis Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Isoniazid
Rifampin
Ethambutol
Pyrazinamide
Otherr
Segment by Application
Hospitals and Clinics
Government Agencies
Non-Profit Organizations
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Lupin
Macleods Pharmaceuticals
Otsuka Pharmaceutical
Johnson & Johnson
Pfizer
Novartis
Abbott
AstraZeneca
Bayer
Johnson & Johnson
Pfizer
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-tuberculosis Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Isoniazid
1.2.3 Rifampin
1.2.4 Ethambutol
1.2.5 Pyrazinamide
1.2.6 Otherr
1.3 Market by Application
1.3.1 Global Anti-tuberculosis Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals and Clinics
1.3.3 Government Agencies
1.3.4 Non-Profit Organizations
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Anti-tuberculosis Therapeutics Market Perspective (2016-2027)
2.2 Anti-tuberculosis Therapeutics Growth Trends by Regions
2.2.1 Anti-tuberculosis Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Anti-tuberculosis Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Anti-tuberculosis Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Anti-tuberculosis Therapeutics Industry Dynamic
2.3.1 Anti-tuberculosis Therapeutics Market Trends
2.3.2 Anti-tuberculosis Therapeutics Market Drivers
2.3.3 Anti-tuberculosis Therapeutics Market Challenges
2.3.4 Anti-tuberculosis Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-tuberculosis Therapeutics Players by Revenue
3.1.1 Global Top Anti-tuberculosis Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Anti-tuberculosis Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Anti-tuberculosis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Anti-tuberculosis Therapeutics Revenue
3.4 Global Anti-tuberculosis Therapeutics Market Concentration Ratio
3.4.1 Global Anti-tuberculosis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-tuberculosis Therapeutics Revenue in 2020
3.5 Anti-tuberculosis Therapeutics Key Players Head office and Area Served
3.6 Key Players Anti-tuberculosis Therapeutics Product Solution and Service
3.7 Date of Enter into Anti-tuberculosis Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-tuberculosis Therapeutics Breakdown Data by Type
4.1 Global Anti-tuberculosis Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Anti-tuberculosis Therapeutics Forecasted Market Size by Type (2022-2027)
5 Anti-tuberculosis Therapeutics Breakdown Data by Application
5.1 Global Anti-tuberculosis Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Anti-tuberculosis Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Anti-tuberculosis Therapeutics Market Size (2016-2027)
6.2 North America Anti-tuberculosis Therapeutics Market Size by Type
6.2.1 North America Anti-tuberculosis Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Anti-tuberculosis Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Anti-tuberculosis Therapeutics Market Size by Type (2016-2027)
6.3 North America Anti-tuberculosis Therapeutics Market Size by Application
6.3.1 North America Anti-tuberculosis Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Anti-tuberculosis Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Anti-tuberculosis Therapeutics Market Size by Application (2016-2027)
6.4 North America Anti-tuberculosis Therapeutics Market Size by Country
6.4.1 North America Anti-tuberculosis Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Anti-tuberculosis Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Anti-tuberculosis Therapeutics Market Size (2016-2027)
7.2 Europe Anti-tuberculosis Therapeutics Market Size by Type
7.2.1 Europe Anti-tuberculosis Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Anti-tuberculosis Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Anti-tuberculosis Therapeutics Market Size by Type (2016-2027)
7.3 Europe Anti-tuberculosis Therapeutics Market Size by Application
7.3.1 Europe Anti-tuberculosis Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Anti-tuberculosis Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Anti-tuberculosis Therapeutics Market Size by Application (2016-2027)
7.4 Europe Anti-tuberculosis Therapeutics Market Size by Country
7.4.1 Europe Anti-tuberculosis Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Anti-tuberculosis Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Anti-tuberculosis Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Anti-tuberculosis Therapeutics Market Size by Type
8.2.1 Asia-Pacific Anti-tuberculosis Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Anti-tuberculosis Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Anti-tuberculosis Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Anti-tuberculosis Therapeutics Market Size by Application
8.3.1 Asia-Pacific Anti-tuberculosis Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Anti-tuberculosis Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Anti-tuberculosis Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Anti-tuberculosis Therapeutics Market Size by Region
8.4.1 Asia-Pacific Anti-tuberculosis Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Anti-tuberculosis Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Anti-tuberculosis Therapeutics Market Size (2016-2027)
9.2 Latin America Anti-tuberculosis Therapeutics Market Size by Type
9.2.1 Latin America Anti-tuberculosis Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Anti-tuberculosis Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Anti-tuberculosis Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Anti-tuberculosis Therapeutics Market Size by Application
9.3.1 Latin America Anti-tuberculosis Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Anti-tuberculosis Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Anti-tuberculosis Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Anti-tuberculosis Therapeutics Market Size by Country
9.4.1 Latin America Anti-tuberculosis Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Anti-tuberculosis Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-tuberculosis Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Type
10.2.1 Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Application
10.3.1 Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Country
10.4.1 Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Lupin
11.1.1 Lupin Company Details
11.1.2 Lupin Business Overview
11.1.3 Lupin Anti-tuberculosis Therapeutics Introduction
11.1.4 Lupin Revenue in Anti-tuberculosis Therapeutics Business (2016-2021)
11.1.5 Lupin Recent Development
11.2 Macleods Pharmaceuticals
11.2.1 Macleods Pharmaceuticals Company Details
11.2.2 Macleods Pharmaceuticals Business Overview
11.2.3 Macleods Pharmaceuticals Anti-tuberculosis Therapeutics Introduction
11.2.4 Macleods Pharmaceuticals Revenue in Anti-tuberculosis Therapeutics Business (2016-2021)
11.2.5 Macleods Pharmaceuticals Recent Development
11.3 Otsuka Pharmaceutical
11.3.1 Otsuka Pharmaceutical Company Details
11.3.2 Otsuka Pharmaceutical Business Overview
11.3.3 Otsuka Pharmaceutical Anti-tuberculosis Therapeutics Introduction
11.3.4 Otsuka Pharmaceutical Revenue in Anti-tuberculosis Therapeutics Business (2016-2021)
11.3.5 Otsuka Pharmaceutical Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Anti-tuberculosis Therapeutics Introduction
11.4.4 Johnson & Johnson Revenue in Anti-tuberculosis Therapeutics Business (2016-2021)
11.4.5 Johnson & Johnson Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Anti-tuberculosis Therapeutics Introduction
11.5.4 Pfizer Revenue in Anti-tuberculosis Therapeutics Business (2016-2021)
11.5.5 Pfizer Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Anti-tuberculosis Therapeutics Introduction
11.6.4 Novartis Revenue in Anti-tuberculosis Therapeutics Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 Abbott
11.7.1 Abbott Company Details
11.7.2 Abbott Business Overview
11.7.3 Abbott Anti-tuberculosis Therapeutics Introduction
11.7.4 Abbott Revenue in Anti-tuberculosis Therapeutics Business (2016-2021)
11.7.5 Abbott Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Anti-tuberculosis Therapeutics Introduction
11.8.4 AstraZeneca Revenue in Anti-tuberculosis Therapeutics Business (2016-2021)
11.8.5 AstraZeneca Recent Development
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Bayer Business Overview
11.9.3 Bayer Anti-tuberculosis Therapeutics Introduction
11.9.4 Bayer Revenue in Anti-tuberculosis Therapeutics Business (2016-2021)
11.9.5 Bayer Recent Development
11.10 Eli Lilly
11.10.1 Eli Lilly Company Details
11.10.2 Eli Lilly Business Overview
11.10.3 Eli Lilly Anti-tuberculosis Therapeutics Introduction
11.10.4 Eli Lilly Revenue in Anti-tuberculosis Therapeutics Business (2016-2021)
11.10.5 Eli Lilly Recent Development
11.11 GlaxoSmithKline
11.11.1 GlaxoSmithKline Company Details
11.11.2 GlaxoSmithKline Business Overview
11.11.3 GlaxoSmithKline Anti-tuberculosis Therapeutics Introduction
11.11.4 GlaxoSmithKline Revenue in Anti-tuberculosis Therapeutics Business (2016-2021)
11.11.5 GlaxoSmithKline Recent Development
11.12 Merck
11.12.1 Merck Company Details
11.12.2 Merck Business Overview
11.12.3 Merck Anti-tuberculosis Therapeutics Introduction
11.12.4 Merck Revenue in Anti-tuberculosis Therapeutics Business (2016-2021)
11.12.5 Merck Recent Development
11.13 Sanofi
11.13.1 Sanofi Company Details
11.13.2 Sanofi Business Overview
11.13.3 Sanofi Anti-tuberculosis Therapeutics Introduction
11.13.4 Sanofi Revenue in Anti-tuberculosis Therapeutics Business (2016-2021)
11.13.5 Sanofi Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Anti-tuberculosis Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Isoniazid
Table 3. Key Players of Rifampin
Table 4. Key Players of Ethambutol
Table 5. Key Players of Pyrazinamide
Table 6. Key Players of Otherr
Table 7. Global Anti-tuberculosis Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Anti-tuberculosis Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Anti-tuberculosis Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Anti-tuberculosis Therapeutics Market Share by Regions (2016-2021)
Table 11. Global Anti-tuberculosis Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Anti-tuberculosis Therapeutics Market Share by Regions (2022-2027)
Table 13. Anti-tuberculosis Therapeutics Market Trends
Table 14. Anti-tuberculosis Therapeutics Market Drivers
Table 15. Anti-tuberculosis Therapeutics Market Challenges
Table 16. Anti-tuberculosis Therapeutics Market Restraints
Table 17. Global Anti-tuberculosis Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Anti-tuberculosis Therapeutics Market Share by Players (2016-2021)
Table 19. Global Top Anti-tuberculosis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-tuberculosis Therapeutics as of 2020)
Table 20. Ranking of Global Top Anti-tuberculosis Therapeutics Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Anti-tuberculosis Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Anti-tuberculosis Therapeutics Product Solution and Service
Table 24. Date of Enter into Anti-tuberculosis Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Anti-tuberculosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Anti-tuberculosis Therapeutics Revenue Market Share by Type (2016-2021)
Table 28. Global Anti-tuberculosis Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Anti-tuberculosis Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Anti-tuberculosis Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Anti-tuberculosis Therapeutics Revenue Market Share by Application (2016-2021)
Table 32. Global Anti-tuberculosis Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Anti-tuberculosis Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Anti-tuberculosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Anti-tuberculosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Anti-tuberculosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Anti-tuberculosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Anti-tuberculosis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Anti-tuberculosis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Anti-tuberculosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Anti-tuberculosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Anti-tuberculosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Anti-tuberculosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Anti-tuberculosis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Anti-tuberculosis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Anti-tuberculosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Anti-tuberculosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Anti-tuberculosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Anti-tuberculosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Anti-tuberculosis Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Anti-tuberculosis Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Anti-tuberculosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Anti-tuberculosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Anti-tuberculosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Anti-tuberculosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Anti-tuberculosis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Anti-tuberculosis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 64. Lupin Company Details
Table 65. Lupin Business Overview
Table 66. Lupin Anti-tuberculosis Therapeutics Product
Table 67. Lupin Revenue in Anti-tuberculosis Therapeutics Business (2016-2021) & (US$ Million)
Table 68. Lupin Recent Development
Table 69. Macleods Pharmaceuticals Company Details
Table 70. Macleods Pharmaceuticals Business Overview
Table 71. Macleods Pharmaceuticals Anti-tuberculosis Therapeutics Product
Table 72. Macleods Pharmaceuticals Revenue in Anti-tuberculosis Therapeutics Business (2016-2021) & (US$ Million)
Table 73. Macleods Pharmaceuticals Recent Development
Table 74. Otsuka Pharmaceutical Company Details
Table 75. Otsuka Pharmaceutical Business Overview
Table 76. Otsuka Pharmaceutical Anti-tuberculosis Therapeutics Product
Table 77. Otsuka Pharmaceutical Revenue in Anti-tuberculosis Therapeutics Business (2016-2021) & (US$ Million)
Table 78. Otsuka Pharmaceutical Recent Development
Table 79. Johnson & Johnson Company Details
Table 80. Johnson & Johnson Business Overview
Table 81. Johnson & Johnson Anti-tuberculosis Therapeutics Product
Table 82. Johnson & Johnson Revenue in Anti-tuberculosis Therapeutics Business (2016-2021) & (US$ Million)
Table 83. Johnson & Johnson Recent Development
Table 84. Pfizer Company Details
Table 85. Pfizer Business Overview
Table 86. Pfizer Anti-tuberculosis Therapeutics Product
Table 87. Pfizer Revenue in Anti-tuberculosis Therapeutics Business (2016-2021) & (US$ Million)
Table 88. Pfizer Recent Development
Table 89. Novartis Company Details
Table 90. Novartis Business Overview
Table 91. Novartis Anti-tuberculosis Therapeutics Product
Table 92. Novartis Revenue in Anti-tuberculosis Therapeutics Business (2016-2021) & (US$ Million)
Table 93. Novartis Recent Development
Table 94. Abbott Company Details
Table 95. Abbott Business Overview
Table 96. Abbott Anti-tuberculosis Therapeutics Product
Table 97. Abbott Revenue in Anti-tuberculosis Therapeutics Business (2016-2021) & (US$ Million)
Table 98. Abbott Recent Development
Table 99. AstraZeneca Company Details
Table 100. AstraZeneca Business Overview
Table 101. AstraZeneca Revenue in Anti-tuberculosis Therapeutics Business (2016-2021) & (US$ Million)
Table 102. AstraZeneca Recent Development
Table 103. Bayer Company Details
Table 104. Bayer Business Overview
Table 105. Bayer Anti-tuberculosis Therapeutics Product
Table 106. Bayer Revenue in Anti-tuberculosis Therapeutics Business (2016-2021) & (US$ Million)
Table 107. Bayer Recent Development
Table 108. Eli Lilly Company Details
Table 109. Eli Lilly Business Overview
Table 110. Eli Lilly Anti-tuberculosis Therapeutics Product
Table 111. Eli Lilly Revenue in Anti-tuberculosis Therapeutics Business (2016-2021) & (US$ Million)
Table 112. Eli Lilly Recent Development
Table 113. GlaxoSmithKline Company Details
Table 114. GlaxoSmithKline Business Overview
Table 115. GlaxoSmithKline Anti-tuberculosis Therapeutics Product
Table 116. GlaxoSmithKline Revenue in Anti-tuberculosis Therapeutics Business (2016-2021) & (US$ Million)
Table 117. GlaxoSmithKline Recent Development
Table 118. Merck Company Details
Table 119. Merck Business Overview
Table 120. Merck Anti-tuberculosis Therapeutics Product
Table 121. Merck Revenue in Anti-tuberculosis Therapeutics Business (2016-2021) & (US$ Million)
Table 122. Merck Recent Development
Table 123. Sanofi Company Details
Table 124. Sanofi Business Overview
Table 125. Sanofi Anti-tuberculosis Therapeutics Product
Table 126. Sanofi Revenue in Anti-tuberculosis Therapeutics Business (2016-2021) & (US$ Million)
Table 127. Sanofi Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-tuberculosis Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Isoniazid Features
Figure 3. Rifampin Features
Figure 4. Ethambutol Features
Figure 5. Pyrazinamide Features
Figure 6. Otherr Features
Figure 7. Global Anti-tuberculosis Therapeutics Market Share by Application: 2020 VS 2027
Figure 8. Hospitals and Clinics Case Studies
Figure 9. Government Agencies Case Studies
Figure 10. Non-Profit Organizations Case Studies
Figure 11. Others Case Studies
Figure 12. Anti-tuberculosis Therapeutics Report Years Considered
Figure 13. Global Anti-tuberculosis Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Anti-tuberculosis Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Anti-tuberculosis Therapeutics Market Share by Regions: 2020 VS 2027
Figure 16. Global Anti-tuberculosis Therapeutics Market Share by Regions (2022-2027)
Figure 17. Global Anti-tuberculosis Therapeutics Market Share by Players in 2020
Figure 18. Global Top Anti-tuberculosis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-tuberculosis Therapeutics as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Anti-tuberculosis Therapeutics Revenue in 2020
Figure 20. Global Anti-tuberculosis Therapeutics Revenue Market Share by Type (2016-2021)
Figure 21. Global Anti-tuberculosis Therapeutics Revenue Market Share by Type (2022-2027)
Figure 22. North America Anti-tuberculosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Anti-tuberculosis Therapeutics Market Share by Type (2016-2027)
Figure 24. North America Anti-tuberculosis Therapeutics Market Share by Application (2016-2027)
Figure 25. North America Anti-tuberculosis Therapeutics Market Share by Country (2016-2027)
Figure 26. United States Anti-tuberculosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Anti-tuberculosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Anti-tuberculosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Anti-tuberculosis Therapeutics Market Share by Type (2016-2027)
Figure 30. Europe Anti-tuberculosis Therapeutics Market Share by Application (2016-2027)
Figure 31. Europe Anti-tuberculosis Therapeutics Market Share by Country (2016-2027)
Figure 32. Germany Anti-tuberculosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Anti-tuberculosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Anti-tuberculosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Anti-tuberculosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Anti-tuberculosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Anti-tuberculosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Anti-tuberculosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Anti-tuberculosis Therapeutics Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Anti-tuberculosis Therapeutics Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Anti-tuberculosis Therapeutics Market Share by Region (2016-2027)
Figure 42. China Anti-tuberculosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Anti-tuberculosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Anti-tuberculosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Anti-tuberculosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Anti-tuberculosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Anti-tuberculosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Anti-tuberculosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Anti-tuberculosis Therapeutics Market Share by Type (2016-2027)
Figure 50. Latin America Anti-tuberculosis Therapeutics Market Share by Application (2016-2027)
Figure 51. Latin America Anti-tuberculosis Therapeutics Market Share by Country (2016-2027)
Figure 52. Mexico Anti-tuberculosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Anti-tuberculosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Anti-tuberculosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Anti-tuberculosis Therapeutics Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Anti-tuberculosis Therapeutics Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Anti-tuberculosis Therapeutics Market Share by Country (2016-2027)
Figure 58. Turkey Anti-tuberculosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Anti-tuberculosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Anti-tuberculosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Lupin Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2016-2021)
Figure 62. Macleods Pharmaceuticals Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2016-2021)
Figure 63. Otsuka Pharmaceutical Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2016-2021)
Figure 64. Johnson & Johnson Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2016-2021)
Figure 65. Pfizer Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2016-2021)
Figure 66. Novartis Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2016-2021)
Figure 67. Abbott Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2016-2021)
Figure 68. AstraZeneca Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2016-2021)
Figure 69. Bayer Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2016-2021)
Figure 70. Eli Lilly Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2016-2021)
Figure 71. GlaxoSmithKline Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2016-2021)
Figure 72. Merck Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2016-2021)
Figure 73. Sanofi Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
世界の結核治療市場 2021：企業別、地域別、種類・用途別 The Tuberculosis Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…- 世界の潜在性結核感染症（LTBI）検査市場規模・現状・予測（2021年-2027年） The Latent Tuberculosis Infection (LTBI) Testing industry can be broken down into several segments, Tuberculin Skin Test (TST), Interferon Gamma Released Assay (IGRA), etc. Across the world, the major players cover Qiagen, Oxford Immunotec, Sanofi, etc. Diagnosing and treating latent tuberculosis (T…
- 世界の結核治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Tuberculosis Treatment Market The global Tuberculosis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the repo…
- 世界の結核治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Tuberculosis Treatment Market The global Tuberculosis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the repo…
- 世界の結核診断・治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Tuberculosis Diagnosis and Treatment Market The global Tuberculosis Diagnosis and Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and h…